Skip to content

Opening book details…

Can I read Early Clinical Experiences of Esketamine Nasal Spray in the UK in Adults with Treatment-Resistant Major Depressive Disorder: Advisory Panel Recommendations on EtoBox?

Early Clinical Experiences of Esketamine Nasal Spray in the UK in Adults with Treatment-Resistant Major Depressive Disorder: Advisory Panel Recommendations by Allan H Young; Mohamed Abdelghani; Mario F Juruena; Viktoriya L Nikolova; Ramin Nilforooshan is a Medicine article available to read on EtoBox.

What is Early Clinical Experiences of Esketamine Nasal Spray in the UK in Adults with Treatment-Resistant Major Depressive Disorder: Advisory Panel Recommendations about?

## Purpose Treatment-resistant depression (TRD) is associated with profound morbidity for patients, placing a significant burden on those affected, the health service and wider society. Despite this, TRD remains chronically underserved in terms of viable treatment options. To address this gap, an advisory panel of psychiatrists and clinical researchers with experience in managing TRD convened to develop best practice statements on the use of esketamine nasal spray, one of the first TRD treatments to be licensed in 30 years. ## Methods During a virtual meeting held on 12th November 2020, the advisory panel shared their experiences of using esketamine nasal spray in their clinical practice. The meeting focused on developing and refining recommendations for setting up and running an efficient esketamine nasal spray clinic for patients living with TRD. At the conclusion of the meeting, agreement was reached on all recommendation statements. ## Results In setting up an esketamine nasal spray clinic, it is important to consider the logistical requirements involved and put measures in place to ensure it runs as efficiently as possible. Educating patients about the treatment and maintainin

Who reads Early Clinical Experiences of Esketamine Nasal Spray in the UK in Adults with Treatment-Resistant Major Depressive Disorder: Advisory Panel Recommendations?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Allan H Young; Mohamed Abdelghani; Mario F Juruena; Viktoriya L Nikolova; Ramin Nilforooshan
Publisher
Informa UK Limited
Published
2023
Language
EN
Field
Medicine (Health Sciences)

More by Allan H Young; Mohamed Abdelghani; Mario F Juruena; Viktoriya L Nikolova; Ramin Nilforooshan

Browse all works by Allan H Young; Mohamed Abdelghani; Mario F Juruena; Viktoriya L Nikolova; Ramin Nilforooshan